# ALLOGENE THERAPEUTICS INC (ALLO)

> Institutional ownership reported to the SEC as of Q3 2026, from Form 13F filings. Source: https://holderbook.com/stocks/ALLO/

- Reporting holders: 3
- Reported value: $30.4K
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [GAMMA Investing LLC](https://holderbook.com/funds/2010235-gamma-investing-llc/) | $25.9K | 16,219 | 0.0% | 4 |
| [Trust Co](https://holderbook.com/funds/1632554-trust-co/) | $3.2K | 2,000 | 0.0% | 1 |
| [Farther Finance Advisors, LLC](https://holderbook.com/funds/1992825-farther-finance-advisors-llc/) | $1.2K | 780 | 0.0% | 12 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q3 2026 | 3 | $30.4K |
| Q2 2026 | 212 | $720.1M |
| Q1 2026 | 207 | $440.7M |
| Q4 2025 | 170 | $223.5M |
| Q3 2025 | 169 | $202.4M |
| Q2 2025 | 156 | $207.5M |
| Q1 2025 | 168 | $286.5M |
| Q4 2024 | 171 | $402.5M |
| Q3 2024 | 153 | $472.6M |
| Q2 2024 | 173 | $395.5M |
| Q1 2024 | 160 | $630.8M |
| Q4 2023 | 168 | $420.5M |